Soleno Therapeutics, Inc.

NASDAQ:SLNO

76.78 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 00003.44600000000000000000000000734.94600.0010.2650.2840.3290.3910.4470.2420.0920.0320.02200000003
Cost of Revenue 000.4940.490.4890.5570.5980.5680.5190.5650.5630.5630.5160.5610.5650.565000000000000819.8472.6890.0420.2090.2220.3990.4280.4610.2570.0560.0220.01800000000
Gross Profit 00-0.494-0.492.957-0.557-0.598-0.568-0.519-0.565-0.563-0.563-0.516-0.561-0.565-0.565000000000000-84.901-2.689-0.0410.0560.061-0.07-0.037-0.014-0.0150.0360.010.00400000003
Gross Profit Ratio 00000.85800000000000000000000000-0.1160-410.2110.217-0.213-0.095-0.031-0.0630.3910.3130.18200000001
Reseach & Development Expenses 21.48630.13812.34214.6028.6896.0435.1415.3163.813.7713.6963.9883.7344.9685.5877.1645.5664.8276.1036.6955.2724.493.7452.762.1922.0921.7141.181.0230.9820.9740.9940.9541.1311.3271.7721.2841.1931.1810.8780.6090.7170.5490.3720.360.7450.5720.703
General & Administrative Expenses 37.30349.19710.8898.4724.143.3183.1692.8542.4022.3322.4672.6432.5962.7672.4642.9792.2512.2562.2482.0031.6081.6151.6952.0121.3651.5581.7661.8671.6851.7072.1951.1581.891.3981.5091.9391.7091.7141.4321.2921.080.5220.7460.3120.20.2480.6040.416
Selling & Marketing Expenses 00-0.4940-0.48900000000000000000000000-00.00100.1140.1740.3420.5770.5380.4980.4670.5060.260.1560.0840.01200000
SG&A 37.30349.19710.3958.4723.6513.3183.1692.8542.4022.3322.4672.6432.5962.7672.4642.9792.2512.2562.2482.0031.6081.6151.6952.0121.3651.5581.7661.8671.6841.7072.1951.2722.0641.742.0862.4772.2072.1811.9381.5521.2370.6060.7580.3120.20.2480.6040.416
Other Expenses 0.3270.8771.6370.4011.0811.0210.3130.299-0.1320.1320.616000.5513.03404.340.7742.8420.5840.2890.0280.1830.2060.567-0.2280.0030.0030.0130.0040-0.6090.02-0.009-0.016-0.096-0.001-0.183-0.0650-3.69-0.31800.238-0.105-0.026-0.0260.077
Operating Expenses 59.11680.21222.73723.47512.3410.3828.318.176.2126.1036.1636.6316.337.7358.05110.1437.8177.0838.3518.6986.886.1055.444.7723.5573.653.483.0472.7072.6893.1692.2663.0182.8713.4134.2493.4923.2193.0542.431.8461.3231.3070.6840.560.9931.1761.119
Operating Income -59.116-80.212-23.231-21.398-12.829-10.861-8.623-8.469-5.61-6.235-6.7795.773-3.001-8.286-11.0859.156-7.957-7.857-11.193-9.282-6.752-6.105-5.623-4.978-3.535-3.878-3.413-3.475-5.199-2.689-3.21-2.21-2.956-2.941-3.45-4.263-3.507-3.183-3.044-2.426-1.846-1.323-1.307-0.684-0.56-0.993-1.1761.881
Operating Income Ratio 0000-3.72300000000000000000000000-0.0070-3,210-8.34-10.417-8.939-8.824-9.537-14.517-34.598-95.125-110.27300000000.627
Total Other Income Expenses Net 3.1343.5961.3772.0772.614-0.4790.1480.1130.1240.1030.0540.0490.1730.1460.0970.2025.105-0.6883.8093.424-7.8737.022-4.385-2.0523.9281.569-3.2220.185-0.9320.139-0.271-0.677-0.7591.164-0.0721.0740.662-0.114.925-9.225-6.01-1.07-1.486-0.15-0.414-0.597-0.981-0.867
Income Before Tax -55.982-76.616-21.854-21.398-11.296-10.861-8.475-8.356-5.486-6.132-6.725-5.724-2.828-8.14-10.988-8.954-2.852-8.545-7.384-5.858-14.6250.889-10.008-7.030.393-2.309-7.214-3.241-6.131-2.551-3.239-2.887-2.592-2.75-3.513-3.189-2.845-3.2931.881-11.651-7.856-2.393-2.793-0.834-0.974-1.59-2.1571.014
Income Before Tax Ratio 0000-3.27800000000000000000000000-0.0080-3,239-10.894-9.132-8.359-8.985-7.134-11.776-35.79358.781-529.59100000000.338
Income Tax Expense 0001.1862.004-2.1640.165-0.005-1.7410.1591.124-1.814-3.5020.4052.937-1.189-5.4530.973-0.967-2.847.255-7.1174.4032.0681.494-0.9144.160.711-1.9621.1010.7560.06821.7-0.0090.047-1.17-4.412-0.073-4.9250.001-1.3710.4281.4860.6250.2050.5450.9291.022
Net Income -55.982-76.616-21.854-21.398-11.296-10.861-8.475-8.351-3.745-6.291-7.849-3.91-2.828-8.14-10.988-8.954-2.852-8.545-7.384-5.858-14.6250.889-10.008-7.030.263-2.736-7.637-3.755-5.025-3.786-3.966-2.887-2.613-2.75-3.513-3.189-2.845-3.2931.881-11.651-7.856-2.393-2.793-0.834-0.974-1.59-2.1571.014
Net Income Ratio 0000-3.27800000000000000000000000-0.0070-3,966-10.894-9.208-8.359-8.985-7.134-11.776-35.79358.781-529.59100000000.338
EPS -1.27-1.83-0.57-0.59-0.33-0.95-0.81-0.88-0.4-0.67-0.84-0.73-0.53-1.53-2.07-1.69-0.54-1.61-2.4-1.97-5.330.45-4.72-3.320.15-1.91-5.63-2.88-3.86-5.87-6.25-8.51-7.3-13.09-16.97-16.16-14.42-24.618.75-125.45-87.04-27.73-149.51-44.64-52.15-85.11-115.4754.28
EPS Diluted -1.27-1.83-0.57-0.59-0.33-0.95-0.81-0.88-0.4-0.67-0.84-0.73-0.53-1.53-2.07-1.69-0.54-1.61-2.4-1.97-5.33-2.85-4.72-3.320.15-1.91-5.63-2.88-3.86-5.87-6.25-8.51-7.3-13.09-16.97-16.16-14.42-24.618.75-125.45-84.58-27.73-149.51-44.64-52.15-85.11-115.4754.28
EBITDA -55.248-78.835-22.737-22.584-12.34-8.871-7.877-7.68-5.724-5.567-5.671-6.139-5.838-7.243-7.561-9.654-7.329-6.594-7.863-8.209-6.39-5.615-4.951-4.2830.883-3.16-2.989-2.555-2.125-2.172-2.517-1.254-2.554-1.929-2.27-4.243-3.458-3.228-3.028-2.411-1.837-1.317-1.3-0.677-0.654-1.007-1.1921.97
EBITDA Ratio 0000-3.58100000000000000000000000-0.0030-2,517-4.732-9.001-5.863-5.806-9.492-14.314-35.087-94.625-109.59100000000.657